Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Completed 3Terminated 1Recruiting 1

Sponsor Class

OTHER 23INDUSTRY 3OTHER_GOV 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Neoplasms 1904Breast Neoplasms 1423Carcinoma, Non-Small-Cell Lung 1176Prostatic Neoplasms 740Colorectal Neoplasms 685Neoplasm Metastasis 623Multiple Myeloma 546Melanoma 527Ovarian Neoplasms 455Lung Neoplasms 446Lymphoma, Non-Hodgkin 385Lymphoma 374Recurrence 371Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 253Head and Neck Neoplasms 246Glioblastoma 219Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 182Squamous Cell Carcinoma of Head and Neck 181Carcinoma 175Uterine Cervical Neoplasms 174Urinary Bladder Neoplasms 174Advanced Solid Tumors 160

Interventions

Tacrolimus 1GPI 1485 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Erectile Dysfunction × Clear all
NCT05332340 2025-03-07

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

Biozeus Biopharmaceutical S.A.

Phase 1 Completed
12 enrolled 10 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT00106392 2010-11-23

A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy

Astellas Pharma Inc

Phase 4 Completed
131 enrolled 13 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT00090376 2008-11-07

Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy

Eisai Inc.

Phase 2 Completed
240 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡